S&P 500Bucket avgCompareDividend-adjusted total return · S&P 500 uses VOO · Aug 19, 2026 – Nov 17, 2026
Loading…
Getting the latest data.
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | Max |
|---|---|---|---|---|---|---|---|---|---|
| Total return | −1.6% | −4.5% | −1.6% | −12.3% | +5.3% | +9.9% | +69.9% | +12.4% | +23.0% |
| Peer average | −1.3% | −3.1% | −0.1% | −6.8% | +13.2% | +17.2% | +58.9% | +25.9% | — |
| S&P 500 · VOO | −1.0% | −2.4% | −4.5% | −4.5% | +8.3% | +10.2% | +72.7% | +68.0% | — |
$21 of every $1,000 in MMSC is Xometry,
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | XMTRXometry, () | Industrials | 2.11% | $210.55 | 8,628 | $1.1M |
| 2 | FROGJFrog | Technology | 1.89% | $188.68 | 8,589 | $944K |
| 3 | —US Dollar | — | 1.87% | $187.22 | 937K | $937K |
| 4 | ZETAZETA Global () | Technology | 1.74% | $174.38 | 24K | $873K |
| 5 | OLLIOllie's Bargain Outlet | Consumer Defensive | 1.58% | $158.04 | 8,127 | $791K |
| 6 | NTSKNetskope, () | Technology | 1.43% | $142.93 | 33K | $715K |
| 7 | VRNSVaronis Systems | Technology | 1.37% | $136.53 | 14K | $683K |
| 8 | SAILSailPoint | Technology | 1.35% | $135.28 | 32K | $677K |
| 9 | TVTXTravere Therapeutics | Healthcare | 1.30% | $130.00 | 13K | $651K |
| 10 | GHGuardant Health | Healthcare | 1.21% | $121.22 | 4,212 | $607K |
| 11 | SYRESpyre Therapeutics | Healthcare | 1.21% | $121.02 | 6,095 | $606K |
| 12 | PTGXProtagonist Therapeutics | Healthcare | 1.09% | $109.45 | 4,388 | $548K |
| 13 | RGENRepligen | Healthcare | 1.05% | $104.77 | 3,221 | $524K |
| 14 | LGNDLigand Pharmaceuticals () | Healthcare | 1.03% | $102.73 | 1,704 | $514K |
| 15 | MANHManhattan Associates | Technology | 1.01% | $100.65 | 1,953 | $504K |
of the $579B in 112 Small cap ETFs
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | XMTR | Xometry, () | 2.11% |
| 2 | FROG | JFrog | 1.89% |
| 3 | ZETA | ZETA Global () | 1.74% |
| 4 | OLLI | Ollie's Bargain Outlet | 1.58% |
| 5 | NTSK | Netskope, () | 1.43% |
| 6 | VRNS | Varonis Systems | 1.37% |
| 7 | SAIL | SailPoint | 1.35% |
| 8 | TVTX | Travere Therapeutics | 1.30% |
| 9 | GH | Guardant Health | 1.21% |
| 10 | SYRE | Spyre Therapeutics | 1.21% |
Estimated yearly cost excludes trading costs and assumes constant assets.
| Ex-date | Paid | Per share |
|---|---|---|
| Dec 13, 2024 | Dec 31, 2024 | $0.0854 |